Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Is a |
hydrocortisonpræparat til topikal anvendelse |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Is a |
neomycin til topikal anvendelse |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Is a |
kombinationspræparat med hydrocortison til topikal anvendelse |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Is a |
diverse øjenpræparater |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
neomycin til topikal anvendelse |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Is a |
Product containing hydrocortisone and neomycin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone (substance) |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin sulfate |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocortisone acetate |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antiinfektiøst middel til huden |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
binyrehormonmiddel |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Baktericid |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Is a |
Product containing neomycin in ophthalmic dosage form |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Is a |
Product containing hydrocortisone in ocular dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Has manufactured dose form |
Ocular dose form (dose form) |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Has manufactured dose form |
Eye drops |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Is a |
Product containing hydrocortisone acetate in ophthalmic dosage form |
false |
Inferred relationship |
Some |
|
|
hydrocortisonacetat 1,5 % + neomycinsulfat 0,5 % øjendråber |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|